DNA damage repair - A new target for cancer therapy

被引：0

作者：

Bechter O.E. ^{[1
]}

机构：

[1] Department of Internal Medicine i, Medical University of Innsbruck, Innsbruck

来源：

memo - Magazine of European Medical Oncology | 2009年 / 2卷 / 1期

关键词：

Checkpoint kinase; Cytostatic drugs; DNA damage repair; DNA damage sensors;

D O I：

10.1007/s12254-009-0092-z

中图分类号：

学科分类号：

摘要：

DNA damage repair is essential for cellular homeostasis and cell survival. Cytostatic drugs and ionizing radiation cause an enormous amount of DNA damage and efficient repair is crucial for sustained cell growth. Hence manipulating DNA damage repair offers a new therapeutic principle, which together with conventional treatment strategies can increase treatment efficiency. In this issue we would like to give a brief overview of the current status of DNA damage repair factors as clinical markers and therapeutic targets. Ongoing and future clinical trials will determine the therapeutic potential of this new target for cancer treatment. © 2009 Springer-Verlag.

引用

页码：1 / 2

页数：1

共 8 条

[1]

Zhou B.-B.S., Bartek J., Targeting the checkpoint kinases: Chemosensitization versus chemoprotection, Nature Reviews Cancer, 4, 3, pp. 216-225, (2004)

[2]

Hakem R., DNA-damage repair

[3]

the good, the bad, and the ugly, EMBO Journal, 27, 4, pp. 589-605, (2008)

[4]

O'Driscoll M., Jeggo P.A., The role of double-strand break repair - Insights from human genetics, Nature Reviews Genetics, 7, 1, pp. 45-54, (2006)

[5]

Ashwell S., Zabludoff S., DNA damage detection and repair pathways - Recent advances with inhibitors of checkpoint kinases in cancer therapy, Clin Cancer Res, 14, pp. 4032-4037, (2008)

[6]

De Lange T., Shelterin: The protein complex that shapes and safeguards human telomeres, Genes and Development, 19, 18, pp. 2100-2110, (2005)

[7]

Kelland L., Targeting the limitless replicative potential of cancer: The telomerase/telomere pathway, Clinical Cancer Research, 13, 17, pp. 4960-4963, (2007)

[8]

Greider C.W., The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity, Cell, 51, pp. 887-898, (1987)

← 1 →